Entity > Corporation > US > New York City New York > Spero Therapeutics
About Spero Therapeutics
Industry: Business & Industrial > Pharmaceuticals & Biotech
More information about Spero Therapeutics
| Company Attribute | Value |
| Address | StreetAddress: 675 Massachusetts Ave Fl 14, AddressLocality: Cambridge, AddressRegion: Massachusetts, PostalCode: 2139, AddressCountry: United States |
| Founding Date | 2013 |
| Name | Spero Therapeutics |
| Number Of Employees | 35 |
| Revenue | $13,025,000 USD |
| Ticker Symbol | NASDAQ: SPRO |
| Url | sperotherapeutics |
| Wikidata | wikidata |
Spero Therapeutics
New York City, US
17 May 2024
Spero Therapeutics
All
News
Images
Maps
Videos
More
Page: 1
Desktop | Laptop Devices
https://www.sperotherapeutics.com/
Spero Therapeutics is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing novel treatments for ...
Rich Sitelinks
People Also Ask
https://finance.yahoo.com › quote › SPRO
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for ...
https://twitter.com/Spero_Tx?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
Twitter Boxes
https://www.biospace.com › employer › spero-therapeu...
200 articles about Spero Therapeutics. Spero Therapeutics Announces First Quarter 2024 Operating Results and Provides a Business Update. 5/15/2024.
https://www.linkedin.com/company/spero-therapeutics
We are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for ...
https://www.cnbc.com › quotes › SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on focused on identifying and developing novel treatments for ...
https://www.pfizer.com › news › press-release-detail › s...
Jun 30, 2021 — (NYSE: PFE) has made a $40 million equity investment in Spero as part of the Pfizer Breakthrough Growth Initiative, a program focused on funding ...
| Entity Home | Kalicube Pro Entity Page |